Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1959 Mar 15;80(6):445–448.

Evaluation of Thenalidine Tartrate (Sandostene) in Dermatological Disorders *

N A Getzler, L P Ereaux
PMCID: PMC1830689  PMID: 13629433

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. A., PERRY S. Agranulocytosis associated with thenalidine (sandostene) tartrate therapy; report of three cases. J Am Med Assoc. 1958 Jul 5;167(10):1207–1210. doi: 10.1001/jama.1958.02990270013004. [DOI] [PubMed] [Google Scholar]
  2. GARBE W. The action of thenaldine tartrate (sandostene) in atopic dermatitis; evaluation of a new antiallergic preparation for control of pruritus and treatment of various allergic dermatoses. Can Med Assoc J. 1958 Sep 1;79(5):378–380. [PMC free article] [PubMed] [Google Scholar]
  3. GAYNES H. E., SHURE N. Critical analysis of a new antihistaminic-antipruritic in allergy. Postgrad Med. 1958 Jan;23(1):61–69. doi: 10.1080/00325481.1958.11691961. [DOI] [PubMed] [Google Scholar]
  4. HARVEY J. H., KALZ F. Alteration of wheal resorption time by intravenous use of an antihistaminic drug and a calcium salt. Can Med Assoc J. 1959 Mar 15;80(6):448–449. [PMC free article] [PubMed] [Google Scholar]
  5. HEITE H. J., SCHRADER C. P. Untersuchungen über den Wirkungsmechanismus des Calcium auf die kleinen Gefässe mit Hilfe der Quaddelresorption. Klin Wochenschr. 1957 Mar 15;35(6):292–295. doi: 10.1007/BF01482161. [DOI] [PubMed] [Google Scholar]
  6. ROTHLIN E., CERLETTI A. Die Pharmakologie des ASC 16 (Sandosten-Calcium-Sandoz). Int Arch Allergy Appl Immunol. 1953;4(3):191–199. doi: 10.1159/000228021. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES